Pharmacological properties of substituted gamma-butyrolactones. Part II. Antoconvulsant action
Sieroslawska, J.; Hano, J.; Sypniewska, M.; Czarnedki, R.; Chojnacka-Wójcik, E.; Harasiewicz, A.
Polish Journal of Pharmacology and Pharmacy 26(6): 516-525
1974
ISSN/ISBN: 0301-0244 PMID: 4475420 Document Number: 76859
Document emailed within 1 workday
Related Documents
Holland, K.D.; McKeon, A.C.; Covey, D.F.; Ferrendelli, J.A. 1990: Binding interactions of convulsant and anticonvulsant gamma-butyrolactones and gamma-thiobutyrolactones with the picrotoxin receptor Journal of Pharmacology and Experimental Therapeutics 254(2): 578-583Delarge, J. 1976: Synthesis and pharmacological properties of some N-acyl pyridine-3-sulfonamides substituted at position 2 Acta Poloniae Pharmaceutica 33(1): 1-6
Misztal, S.; Boksa, J.; Chojnacka-Wójcik, E.; Tatarczyńska, E.; Lewandowska, A. 1987: Synthesis and pharmacological properties of some 2-substituted 1-(3-pyridyl)-1,2,3,4-tetrahydro-beta-carbolines Polish Journal of Pharmacology and Pharmacy 39(1): 97-103
Brancaccio, G.; Lettieri, G.; Monforte, P.; Larizza, A. 1982: Synthesis and pharmacological properties of some 2-substituted dibenz[2,3:6,7]-3a,12b-dihydrooxepin[4,5-d]1,3-dioxolane derivatives Il Farmaco; Edizione Scientifica 37(11): 711-718
Graczyk, J.; Kamińska, A.; Szadowska, A.; Tkaczyński, T.; Urbańska, A. 1976: Synthesis and pharmacological properties of some new diphenylacetic acid amides substituted at the nitrogen atom Acta Poloniae Pharmaceutica 33(5): 585-592
Schoepp, D.D.; Ornstein, P.L.; Leander, J.D.; Lodge, D.; Salhoff, C.R.; Zeman, S.; Zimmerman, D.M. 1990: Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action Journal of Pharmacology and Experimental Therapeutics 255(3): 1301-1308
Zweig, J.I.; Herz, M.L.; Mclaughlin, W.L.; Bhuthimethee, V. 1977: Drug activation by gamma irradiation: a new direction for molecular design. Part I: In vitro and in vivo studies of a substituted polyaminoaryl nitrile Cancer Treatment Reports 61(3): 419-423
Kapic, E.; Becic, F.; Kusturica, J. 2004: Basiliximab, mechanism of action and pharmacological properties Medicinski Arhiv 58(6): 373-376
Caminero, A.B.; Frank, A.; Barreiro, P.; Díez Tejedor, E. 1995: Nootropic agents: a review of their pharmacological properties, mechanisms of action and therapeutic uses Revista Clinica Espanola 195(3): 172-179
Cosnier, D.; Duchene-Marullaz, P.; Grimal, J.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate Arzneimittel-Forschung 25(10): 1557-1561
Cosnier, D.; Labrid, C.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis Arzneimittel-Forschung 25(11): 1802-1806
Zabska, R.; Jakóbiec, T.; Dobek, R.; Wilimowski, M.; Barczyńska, J.; Kedzierska-Goździk, L.; Wojewódzki, W.; Rutkowska, M.; Duś, E.; Szelag, A. 1991: Synthesis and pharmacological properties of derivatives of alpha-amino-beta-(p-chlorobenzoyl)-propionic acid and alpha-amino-gamma-(p-chlorophenyl)-tetrahydrofuran-2-one Polish Journal of Pharmacology and Pharmacy 43(4): 271-280
Ernest, K. 1975: Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters Polish Journal of Pharmacology and Pharmacy 27(4): 381-398
Carboni, S.; Da Settimo, A.; Bertini, D.; Ferrarini, P.L.; Livi, O.; Tonetti, I. 1975: Preparation and pharmacological study of some N-substituted amino-1,8-naphthyridines Il Farmaco; Edizione Scientifica 30(3): 185-196
Pawłowski, M.; Drabczyńska, A.; Gorczyca, M.; Malec, D.; Modzelewski, J. 1994: Synthesis and pharmacological screening of novel 10-substituted diazepino-[2,1-f]-purines Acta Poloniae Pharmaceutica 51(4-5): 385-391
Chernikh, V.P.; Petiunin, G.P.; Krasnovskaia, O.O. 1972: Synthesis and pharmacological activity of substituted amides of pyridinecarboxylic acids Farmatsevtychnyi Zhurnal 27(1): 16-18
Mishra, P.; Joshi, G.K.; Shakya, A.K.; Agrawal, R.K.; Patnaik, G.K. 1992: Pharmacological screening of few new 2-(substituted acetyl) amino-5-alkyl-1,3,4-oxadiazoles Indian Journal of Physiology and Pharmacology 36(4): 247-250
Gutkowska, B.; Wasiak, J. 1984: Synthesis of various 5,5-substituted derivatives of 3-dialkylamino-alkylohydantoin with potential pharmacological activity Acta Poloniae Pharmaceutica 41(3): 307-311
Teubner, H.; Weuffen, W.; Höppe, H. 1974: Relationships between chemical constitution and antifungal action. 26. Antifungal and anthelminthic action of various newly substituted benzylisocyanates, isothiocyanatomethyl- and beta-isothiocyanatepropionyl compounds Archiv für Experimentelle Veterinarmedizin 28(2): 249-259
Novelli, F.; Sparatore, F. 1996: Preparation and pharmacological activities of spiro[3,4-dihydro-6/7-R-1,2,4-benzotriazine-3,4'-(1'-substituted)piperi dines Farmaco 51(8-9): 541-550